Global Carmustine Market Growth 2022-2028

Publisher Name :
Date: 19-Jan-2022
No. of pages: 108

As the global economy mends, the 2021 growth of Carmustine will have significant change from previous year. According to our (LP Information) latest study, the global Carmustine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Carmustine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Carmustine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Carmustine market, reaching US$ million by the year 2028. As for the Europe Carmustine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Carmustine players cover Amneal Pharms, Arbor Pharms, Emcure Pharms, and Navinta, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Carmustine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

- 100mg Injection

- 125mg Injection

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

- Glioma

- Glioblastoma Multiforme

- Medulloblastoma and Astrocytoma

- Multiple Myeloma

- Lymphoma

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

- Amneal Pharms

- Arbor Pharms

- Emcure Pharms

- Navinta

- STI Pharma

- Obvius Pharmaceuticals

- MGI Pharma

- Marcan Pharmaceuticals

- Eisai

- Bristol-Myers Squibb

- Pharmaplan

- Sanli Ilac

- Zydus Pharmaceuticals 

- Tianjin Kingyork

Global Carmustine Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Carmustine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Carmustine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Carmustine by Country/Region, 2017, 2022 & 2028
2.2 Carmustine Segment by Type
2.2.1 100mg Injection
2.2.2 125mg Injection
2.3 Carmustine Sales by Type
2.3.1 Global Carmustine Sales Market Share by Type (2017-2022)
2.3.2 Global Carmustine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Carmustine Sale Price by Type (2017-2022)
2.4 Carmustine Segment by Application
2.4.1 Glioma
2.4.2 Glioblastoma Multiforme
2.4.3 Medulloblastoma and Astrocytoma
2.4.4 Multiple Myeloma
2.4.5 Lymphoma
2.4.6 Other
2.5 Carmustine Sales by Application
2.5.1 Global Carmustine Sale Market Share by Application (2017-2022)
2.5.2 Global Carmustine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Carmustine Sale Price by Application (2017-2022)
3 Global Carmustine by Company
3.1 Global Carmustine Breakdown Data by Company
3.1.1 Global Carmustine Annual Sales by Company (2020-2022)
3.1.2 Global Carmustine Sales Market Share by Company (2020-2022)
3.2 Global Carmustine Annual Revenue by Company (2020-2022)
3.2.1 Global Carmustine Revenue by Company (2020-2022)
3.2.2 Global Carmustine Revenue Market Share by Company (2020-2022)
3.3 Global Carmustine Sale Price by Company
3.4 Key Manufacturers Carmustine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Carmustine Product Location Distribution
3.4.2 Players Carmustine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Carmustine by Geographic Region
4.1 World Historic Carmustine Market Size by Geographic Region (2017-2022)
4.1.1 Global Carmustine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Carmustine Annual Revenue by Geographic Region
4.2 World Historic Carmustine Market Size by Country/Region (2017-2022)
4.2.1 Global Carmustine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Carmustine Annual Revenue by Country/Region
4.3 Americas Carmustine Sales Growth
4.4 APAC Carmustine Sales Growth
4.5 Europe Carmustine Sales Growth
4.6 Middle East & Africa Carmustine Sales Growth
5 Americas
5.1 Americas Carmustine Sales by Country
5.1.1 Americas Carmustine Sales by Country (2017-2022)
5.1.2 Americas Carmustine Revenue by Country (2017-2022)
5.2 Americas Carmustine Sales by Type
5.3 Americas Carmustine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carmustine Sales by Region
6.1.1 APAC Carmustine Sales by Region (2017-2022)
6.1.2 APAC Carmustine Revenue by Region (2017-2022)
6.2 APAC Carmustine Sales by Type
6.3 APAC Carmustine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Carmustine by Country
7.1.1 Europe Carmustine Sales by Country (2017-2022)
7.1.2 Europe Carmustine Revenue by Country (2017-2022)
7.2 Europe Carmustine Sales by Type
7.3 Europe Carmustine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Carmustine by Country
8.1.1 Middle East & Africa Carmustine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Carmustine Revenue by Country (2017-2022)
8.2 Middle East & Africa Carmustine Sales by Type
8.3 Middle East & Africa Carmustine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Carmustine
10.3 Manufacturing Process Analysis of Carmustine
10.4 Industry Chain Structure of Carmustine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Carmustine Distributors
11.3 Carmustine Customer
12 World Forecast Review for Carmustine by Geographic Region
12.1 Global Carmustine Market Size Forecast by Region
12.1.1 Global Carmustine Forecast by Region (2023-2028)
12.1.2 Global Carmustine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Carmustine Forecast by Type
12.7 Global Carmustine Forecast by Application
13 Key Players Analysis
13.1 Amneal Pharms
13.1.1 Amneal Pharms Company Information
13.1.2 Amneal Pharms Carmustine Product Offered
13.1.3 Amneal Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amneal Pharms Main Business Overview
13.1.5 Amneal Pharms Latest Developments
13.2 Arbor Pharms
13.2.1 Arbor Pharms Company Information
13.2.2 Arbor Pharms Carmustine Product Offered
13.2.3 Arbor Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Arbor Pharms Main Business Overview
13.2.5 Arbor Pharms Latest Developments
13.3 Emcure Pharms
13.3.1 Emcure Pharms Company Information
13.3.2 Emcure Pharms Carmustine Product Offered
13.3.3 Emcure Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Emcure Pharms Main Business Overview
13.3.5 Emcure Pharms Latest Developments
13.4 Navinta
13.4.1 Navinta Company Information
13.4.2 Navinta Carmustine Product Offered
13.4.3 Navinta Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Navinta Main Business Overview
13.4.5 Navinta Latest Developments
13.5 STI Pharma
13.5.1 STI Pharma Company Information
13.5.2 STI Pharma Carmustine Product Offered
13.5.3 STI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 STI Pharma Main Business Overview
13.5.5 STI Pharma Latest Developments
13.6 Obvius Pharmaceuticals
13.6.1 Obvius Pharmaceuticals Company Information
13.6.2 Obvius Pharmaceuticals Carmustine Product Offered
13.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Obvius Pharmaceuticals Main Business Overview
13.6.5 Obvius Pharmaceuticals Latest Developments
13.7 MGI Pharma
13.7.1 MGI Pharma Company Information
13.7.2 MGI Pharma Carmustine Product Offered
13.7.3 MGI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 MGI Pharma Main Business Overview
13.7.5 MGI Pharma Latest Developments
13.8 Marcan Pharmaceuticals
13.8.1 Marcan Pharmaceuticals Company Information
13.8.2 Marcan Pharmaceuticals Carmustine Product Offered
13.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Marcan Pharmaceuticals Main Business Overview
13.8.5 Marcan Pharmaceuticals Latest Developments
13.9 Eisai
13.9.1 Eisai Company Information
13.9.2 Eisai Carmustine Product Offered
13.9.3 Eisai Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Eisai Main Business Overview
13.9.5 Eisai Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Carmustine Product Offered
13.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 Pharmaplan
13.11.1 Pharmaplan Company Information
13.11.2 Pharmaplan Carmustine Product Offered
13.11.3 Pharmaplan Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Pharmaplan Main Business Overview
13.11.5 Pharmaplan Latest Developments
13.12 Sanli Ilac
13.12.1 Sanli Ilac Company Information
13.12.2 Sanli Ilac Carmustine Product Offered
13.12.3 Sanli Ilac Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sanli Ilac Main Business Overview
13.12.5 Sanli Ilac Latest Developments
13.13 Zydus Pharmaceuticals 
13.13.1 Zydus Pharmaceuticals  Company Information
13.13.2 Zydus Pharmaceuticals  Carmustine Product Offered
13.13.3 Zydus Pharmaceuticals  Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Zydus Pharmaceuticals  Main Business Overview
13.13.5 Zydus Pharmaceuticals  Latest Developments
13.14 Tianjin Kingyork
13.14.1 Tianjin Kingyork Company Information
13.14.2 Tianjin Kingyork Carmustine Product Offered
13.14.3 Tianjin Kingyork Carmustine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Tianjin Kingyork Main Business Overview
13.14.5 Tianjin Kingyork Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Carmustine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Carmustine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 125mg Injection
Table 5. Global Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Carmustine Sales Market Share by Type (2017-2022)
Table 7. Global Carmustine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Carmustine Revenue Market Share by Type (2017-2022)
Table 9. Global Carmustine Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Carmustine Sales Market Share by Application (2017-2022)
Table 12. Global Carmustine Revenue by Application (2017-2022)
Table 13. Global Carmustine Revenue Market Share by Application (2017-2022)
Table 14. Global Carmustine Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Carmustine Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Carmustine Sales Market Share by Company (2020-2022)
Table 17. Global Carmustine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Carmustine Revenue Market Share by Company (2020-2022)
Table 19. Global Carmustine Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Carmustine Producing Area Distribution and Sales Area
Table 21. Players Carmustine Products Offered
Table 22. Carmustine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Carmustine Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Carmustine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Carmustine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Carmustine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Carmustine Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Carmustine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Carmustine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Carmustine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Carmustine Sales Market Share by Country (2017-2022)
Table 35. Americas Carmustine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Carmustine Revenue Market Share by Country (2017-2022)
Table 37. Americas Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Carmustine Sales Market Share by Type (2017-2022)
Table 39. Americas Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Carmustine Sales Market Share by Application (2017-2022)
Table 41. APAC Carmustine Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Carmustine Sales Market Share by Region (2017-2022)
Table 43. APAC Carmustine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Carmustine Revenue Market Share by Region (2017-2022)
Table 45. APAC Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Carmustine Sales Market Share by Type (2017-2022)
Table 47. APAC Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Carmustine Sales Market Share by Application (2017-2022)
Table 49. Europe Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Carmustine Sales Market Share by Country (2017-2022)
Table 51. Europe Carmustine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Carmustine Revenue Market Share by Country (2017-2022)
Table 53. Europe Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Carmustine Sales Market Share by Type (2017-2022)
Table 55. Europe Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Carmustine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Carmustine Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Carmustine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Carmustine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Carmustine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Carmustine Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Carmustine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Carmustine Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Carmustine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Carmustine
Table 66. Key Market Challenges & Risks of Carmustine
Table 67. Key Industry Trends of Carmustine
Table 68. Carmustine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Carmustine Distributors List
Table 71. Carmustine Customer List
Table 72. Global Carmustine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Carmustine Sales Market Forecast by Region
Table 74. Global Carmustine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Carmustine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Carmustine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Carmustine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Carmustine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Carmustine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Carmustine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Carmustine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Carmustine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Carmustine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Carmustine Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Carmustine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Carmustine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Carmustine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Carmustine Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Carmustine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Carmustine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Carmustine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Amneal Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 93. Amneal Pharms Carmustine Product Offered
Table 94. Amneal Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Amneal Pharms Main Business
Table 96. Amneal Pharms Latest Developments
Table 97. Arbor Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 98. Arbor Pharms Carmustine Product Offered
Table 99. Arbor Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Arbor Pharms Main Business
Table 101. Arbor Pharms Latest Developments
Table 102. Emcure Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 103. Emcure Pharms Carmustine Product Offered
Table 104. Emcure Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Emcure Pharms Main Business
Table 106. Emcure Pharms Latest Developments
Table 107. Navinta Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 108. Navinta Carmustine Product Offered
Table 109. Navinta Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Navinta Main Business
Table 111. Navinta Latest Developments
Table 112. STI Pharma Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 113. STI Pharma Carmustine Product Offered
Table 114. STI Pharma Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. STI Pharma Main Business
Table 116. STI Pharma Latest Developments
Table 117. Obvius Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 118. Obvius Pharmaceuticals Carmustine Product Offered
Table 119. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Obvius Pharmaceuticals Main Business
Table 121. Obvius Pharmaceuticals Latest Developments
Table 122. MGI Pharma Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 123. MGI Pharma Carmustine Product Offered
Table 124. MGI Pharma Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. MGI Pharma Main Business
Table 126. MGI Pharma Latest Developments
Table 127. Marcan Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 128. Marcan Pharmaceuticals Carmustine Product Offered
Table 129. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Marcan Pharmaceuticals Main Business
Table 131. Marcan Pharmaceuticals Latest Developments
Table 132. Eisai Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 133. Eisai Carmustine Product Offered
Table 134. Eisai Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Eisai Main Business
Table 136. Eisai Latest Developments
Table 137. Bristol-Myers Squibb Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 138. Bristol-Myers Squibb Carmustine Product Offered
Table 139. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Bristol-Myers Squibb Main Business
Table 141. Bristol-Myers Squibb Latest Developments
Table 142. Pharmaplan Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 143. Pharmaplan Carmustine Product Offered
Table 144. Pharmaplan Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Pharmaplan Main Business
Table 146. Pharmaplan Latest Developments
Table 147. Sanli Ilac Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 148. Sanli Ilac Carmustine Product Offered
Table 149. Sanli Ilac Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Sanli Ilac Main Business
Table 151. Sanli Ilac Latest Developments
Table 152. Zydus Pharmaceuticals  Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 153. Zydus Pharmaceuticals  Carmustine Product Offered
Table 154. Zydus Pharmaceuticals  Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Zydus Pharmaceuticals  Main Business
Table 156. Zydus Pharmaceuticals  Latest Developments
Table 157. Tianjin Kingyork Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 158. Tianjin Kingyork Carmustine Product Offered
Table 159. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Tianjin Kingyork Main Business
Table 161. Tianjin Kingyork Latest Developments
List of Figures
Figure 1. Picture of Carmustine
Figure 2. Carmustine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Carmustine Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Carmustine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Carmustine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100mg Injection
Figure 10. Product Picture of 125mg Injection
Figure 11. Global Carmustine Sales Market Share by Type in 2021
Figure 12. Global Carmustine Revenue Market Share by Type (2017-2022)
Figure 13. Carmustine Consumed in Glioma
Figure 14. Global Carmustine Market: Glioma (2017-2022) & (K Pcs)
Figure 15. Carmustine Consumed in Glioblastoma Multiforme
Figure 16. Global Carmustine Market: Glioblastoma Multiforme (2017-2022) & (K Pcs)
Figure 17. Carmustine Consumed in Medulloblastoma and Astrocytoma
Figure 18. Global Carmustine Market: Medulloblastoma and Astrocytoma (2017-2022) & (K Pcs)
Figure 19. Carmustine Consumed in Multiple Myeloma
Figure 20. Global Carmustine Market: Multiple Myeloma (2017-2022) & (K Pcs)
Figure 21. Carmustine Consumed in Lymphoma
Figure 22. Global Carmustine Market: Lymphoma (2017-2022) & (K Pcs)
Figure 23. Carmustine Consumed in Other
Figure 24. Global Carmustine Market: Other (2017-2022) & (K Pcs)
Figure 25. Global Carmustine Sales Market Share by Application (2017-2022)
Figure 26. Global Carmustine Revenue Market Share by Application in 2021
Figure 27. Carmustine Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Carmustine Revenue Market Share by Company in 2021
Figure 29. Global Carmustine Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Carmustine Revenue Market Share by Geographic Region in 2021
Figure 31. Global Carmustine Sales Market Share by Region (2017-2022)
Figure 32. Global Carmustine Revenue Market Share by Country/Region in 2021
Figure 33. Americas Carmustine Sales 2017-2022 (K Pcs)
Figure 34. Americas Carmustine Revenue 2017-2022 ($ Millions)
Figure 35. APAC Carmustine Sales 2017-2022 (K Pcs)
Figure 36. APAC Carmustine Revenue 2017-2022 ($ Millions)
Figure 37. Europe Carmustine Sales 2017-2022 (K Pcs)
Figure 38. Europe Carmustine Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Carmustine Sales 2017-2022 (K Pcs)
Figure 40. Middle East & Africa Carmustine Revenue 2017-2022 ($ Millions)
Figure 41. Americas Carmustine Sales Market Share by Country in 2021
Figure 42. Americas Carmustine Revenue Market Share by Country in 2021
Figure 43. United States Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Carmustine Sales Market Share by Region in 2021
Figure 48. APAC Carmustine Revenue Market Share by Regions in 2021
Figure 49. China Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Carmustine Sales Market Share by Country in 2021
Figure 56. Europe Carmustine Revenue Market Share by Country in 2021
Figure 57. Germany Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Carmustine Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Carmustine Revenue Market Share by Country in 2021
Figure 64. Egypt Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Carmustine Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Carmustine in 2021
Figure 70. Manufacturing Process Analysis of Carmustine
Figure 71. Industry Chain Structure of Carmustine
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs